Becker's Healthcare August 9, 2024
Patsy Newitt

Walgreens could sell off its stake in primary care chain VillageMD — which it acquired in 2021 in a $5.2 billion deal — according to an Aug. 7 Securities and Exchange Commission filing.

Here are five things to know:

1. Walgreens is “currently evaluating a variety of options with respect to VillageMD in light of ongoing investments by the company in VillageMD’s businesses and VillageMD’s substantial ongoing and expected future cash requirement,” the filing said, adding that the options could include sale of “all or part” of VillageMD, as well as possible restructuring options.

2. In the second fiscal quarter of 2024, Walgreens saw a $5.8 billion loss because of an investment devaluation in the primary care clinic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Pharma, Pharma / Biotech, Primary care, Provider
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Does PBM Market Share Vary by Payer Type?
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
Pharma Pulse 9/13/24: AI Adoption for Clinical Trial Design, Comparing Biologics and Biosimilars & more

Share This Article